Zhen Bm Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhen Bm Pan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Guo-Qian He
Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, PR China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, PR China
1 shared publication - Ju Gao
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P.R. China
1 shared publication - Ling Bm Xiao
Sichuan University, Chengdu, Sichuan, P.R. China
1 shared publication - Mingyan Jiang
Department of Pediatrics, West China Second University Hospital, Sichuan University, China
1 shared publication - Wei Wang
Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China
1 shared publication - Xia Guo
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P.R. China
1 shared publication
Latest Publications
- Open Access
- 7 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (45) , e45583
Osteopetrosis misdiagnosed as congenital cytomegalovirus infection: A case report and literature review
Rationale: Infantile malignant osteopetrosis (IMO) (OMIM 259700) is a rare autosomal recessive disease that is caused by defective function of osteoclasts or a reduced number of osteoclasts, resulting in extensive bone sclerosis. The morbidity and mortality rates are extremely high. It may have similar clinical manifestations with congenital cytomegalovirus infection. Due to limited knowledge and heterogenous manifestations, clinical early diagnosis of the disease is challenging. Patient concerns: We reported a case of a 3-month, 15-day-old female child who presented with hematologic abnormalities, hepatosplenomegaly, and optic nerve abnormalities. The child was misdiagnosed congenital cytomegalovirus at the initial diagnosis. However, the child’s condition did not improve significantly after antiviral treatment. Fortunately, the child was then genetically tested for bone marrow failure disorders. Diagnoses: Infantile malignant osteopetrosis. Interventions: The treatment involved ganciclovir and transfusion of blood products. However, after 3 weeks of antiviral treatment, the child did not improve significantly. At that time, bone marrow failure disease and immunodeficiency disease gene test report suggested IMO. Her parents refused to do hematopoietic stem cell transplantation. Outcomes: Oral valganciclovir and transfusion of blood products treatment was continued. Lessons: Our report expands the understanding of IMO disease. It is important that patients with clinical features and hematologic findings similar to infection should undergo a thorough clinical evaluation and timely genetic analysis to identify the causative mutation to avoid delays in diagnosis and treatment.
- 7 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (45) , e45583
Open AccessOsteopetrosis misdiagnosed as congenital cytomegalovirus infection: A case report and literature review
Rationale: Infantile malignant osteopetrosis (IMO) (OMIM 259700) is a rare autosomal recessive disease that is caused by defective function of osteoclasts or a reduced number of osteoclasts, resulting in extensive bone sclerosis. The morbidity and mortality rates are extremely high. It may have similar clinical manifestations with congenital cytomegalovirus infection. Due to limited knowledge and heterogenous manifestations, clinical early diagnosis of the disease is challenging. Patient concerns: We reported a case of a 3-month, 15-day-old female child who presented with hematologic abnormalities, hepatosplenomegaly, and optic nerve abnormalities. The child was misdiagnosed congenital cytomegalovirus at the initial diagnosis. However, the child’s condition did not improve significantly after antiviral treatment. Fortunately, the child was then genetically tested for bone marrow failure disorders. Diagnoses: Infantile malignant osteopetrosis. Interventions: The treatment involved ganciclovir and transfusion of blood products. However, after 3 weeks of antiviral treatment, the child did not improve significantly. At that time, bone marrow failure disease and immunodeficiency disease gene test report suggested IMO. Her parents refused to do hematopoietic stem cell transplantation. Outcomes: Oral valganciclovir and transfusion of blood products treatment was continued. Lessons: Our report expands the understanding of IMO disease. It is important that patients with clinical features and hematologic findings similar to infection should undergo a thorough clinical evaluation and timely genetic analysis to identify the causative mutation to avoid delays in diagnosis and treatment.
- Open Access
- 10 May 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (19) , e38148
Anti-Hu antibody associated paraneoplastic neurological syndrome in a child with ganglioneuroblastoma: A rare case report and literature review
Rationale: Paraneoplastic neurological syndrome with anti-Hu antibody (Hu-PNS) is a neurological disorder that occur in patients with malignancy. The syndrome has a wide range of presentations and can present before diagnosis of primary malignancy. Familiarity with these paraneoplastic neurological syndromes can help early recognition and take appropriate regimens. Patients concerns: Diagnosis and treatment of Hu-PNS. Diagnoses: This is retrospective study that analyzed the clinical data of this case. Through retrospective analysis and targeted antibody screening, serum anti-Hu antibody was detected. Subsequent spinal imaging revealed a mass in the paraspinal region, which was confirmed as ganglioneuroblastoma by pathologic examination. Interventions: The child was treated with a course of intravenous immunoglobulin and radical surgical operation without chemotherapy. Outcomes: The neurological symptoms were gradually improved and no signs indicate disease progression or tumor recurrence. Lessons: Hu-PNS has rarely been reported in children with ganglioneuroblastomas. They can mimic non-neoplastic processes, making detection and diagnosis difficult. Serum and/or cerebrospinal fluid onconeural antibody can strongly indicate occult cancers. Early detection of paraneoplastic neurological syndromes can help take appropriate regimens and improve prognosis.
- 10 May 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (19) , e38148
Open AccessAnti-Hu antibody associated paraneoplastic neurological syndrome in a child with ganglioneuroblastoma: A rare case report and literature review
Rationale: Paraneoplastic neurological syndrome with anti-Hu antibody (Hu-PNS) is a neurological disorder that occur in patients with malignancy. The syndrome has a wide range of presentations and can present before diagnosis of primary malignancy. Familiarity with these paraneoplastic neurological syndromes can help early recognition and take appropriate regimens. Patients concerns: Diagnosis and treatment of Hu-PNS. Diagnoses: This is retrospective study that analyzed the clinical data of this case. Through retrospective analysis and targeted antibody screening, serum anti-Hu antibody was detected. Subsequent spinal imaging revealed a mass in the paraspinal region, which was confirmed as ganglioneuroblastoma by pathologic examination. Interventions: The child was treated with a course of intravenous immunoglobulin and radical surgical operation without chemotherapy. Outcomes: The neurological symptoms were gradually improved and no signs indicate disease progression or tumor recurrence. Lessons: Hu-PNS has rarely been reported in children with ganglioneuroblastomas. They can mimic non-neoplastic processes, making detection and diagnosis difficult. Serum and/or cerebrospinal fluid onconeural antibody can strongly indicate occult cancers. Early detection of paraneoplastic neurological syndromes can help take appropriate regimens and improve prognosis.